Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

RVMD stock hub

Revolution Medicines, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RVMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

RVMD

In the news

Latest news · RVMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-76.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-41.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RVMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001628171
Company name	Revolution Medicines, Inc.
Country	United States
Country code	US
Cusip	76155X100
Employees	883
Employees Change	349%
Employees Change Percent	65.36
Enterprise value	$28.7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-02-13
Isin	US76155X1000
Last refreshed	2026-05-10
Market cap	$30.1B
Market cap category	Large-Cap
Price	$142
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	RVMD
Website	https://www.revmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.55%
EV Sales Forward	277.06x
FCF yield	-3.55%
P/B ratio	18.93x
PS Forward	291.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-1.1B
Net Income	$-1.4B
Net Income Growth Years	0%
Profit Per Employee	$-1.6M
ROA	-37.53
Roa5y	-21.66
ROCE	-70.61
ROE	-76.67
Roe5y	-39.1
ROIC	-41.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	276.9%
Cagr3y	79.92%
Cagr5y	36.84%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$2.3B
Cash	$1.9B
Current Assets	$2B
Current Liabilities	$289.6M
Debt	$437.3M
Debt Equity	$0.29
Equity	$1.5B
Interest Coverage	-38.07
Liabilities	$753.8M
Long Term Assets	$285.8M
Long Term Liabilities	$464.2M
Net Cash	$1.5B
Net Cash By Market Cap	$4.88
Net Cash Growth	-25.28%
Net Debt Equity	$-0.98
Tangible Book Value	$1.4B
Tangible Book Value Per Share	$7.14
WACC	11.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.8
Net Working Capital	$-213.2M
Quick ratio	6.59
Working Capital	$1.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	276.55%
200-day SMA	79.03
3Y total return	482.62%
50-day SMA	115.9
50-day SMA vs 200-day SMA	50over200
5Y total return	379.74%
All Time High	155.7
All Time High Change	-8.92%
All Time High Date	2026-04-16
All Time Low	14.08
All Time Low Change	907.17%
All Time Low Date	2022-05-12
ATR	7.35
Beta	1.41
Beta1y	1.98
Beta2y	1.51
Ch YTD	78.04
High	144.6
High52	155.7
High52 Date	2026-04-16
High52ch	-8.92%
Low	140.5
Low52	34
Low52 Date	2025-08-07
Low52ch	317.09%
Ma50ch	22.35%
Premarket Change Percent	0.34
Premarket Price	$143
Premarket Volume	1,616
Price vs 200-day SMA	79.44%
RSI	57.43
RSI Monthly	84.16
RSI Weekly	72.1
Sharpe ratio	2.2x
Sortino ratio	5.38
Total Return	-10.96%
Tr YTD	78.04
Tr1m	47.27%
Tr1w	1.67%
Tr3m	45.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	19
Analyst Count Top	7
Analyst Price Target Top	$182
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.84
Earnings Revenue Estimate	6,100,000x
Operating Income	$-1.4B
Price target	$145
Price Target Change	$1.92
Price Target Change Top	$28.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	193,201,656%
Float Percent	90.88%
Shares Insiders	2.22%
Shares Institutions	86.14%
Shares Out	212,596,462
Shares Qo Q	0.73%
Shares Yo Y	10.96%
Short Float	6.93%
Short Ratio	4.25
Short Shares	6.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-1.3B
Average Volume	4,655,161.05x
Bv Per Share	7.49
CAPEX	$-14.3M
Ch1m	47.27
Ch1w	1.67
Ch1y	276.6
Ch3m	45.46
Ch3y	482.6
Ch5y	379.7
Ch6m	132.4
Change	-0.49%
Change From Open	-0.53
Close	142.5
Days Gap	0.04
Depreciation Amortization	8,437,000
Dollar Volume	301,345,824.6
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-1.4B
EBITDA	$-1.4B
EPS	$-7.12
F Score	1
FCF	$-1.1B
FCF EV Yield	-3.74x
FCF Per Share	$-5.04
Financing CF	859,394,000
Fiscal Year End	December
Founded	2,014
Goodwill	14,608,000
Investing CF	306,622,000
Ipr	734.2
Iprfo	402.7
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	92.1
Ma150ch	53.98%
Ma20	143.6
Ma20ch	-1.22%
Net CF	108,545,000
Next Earnings Date	2026-08-05
Open	142.6
Optionable	Yes
Position In Range	31.37
Post Close	141.8
Postmarket Change Percent	-0.3
Postmarket Price	$141
Ppne	161,370,000
Pre Close	142.5
Price Date	2026-05-08
Ptbv Ratio	21.09
Relative Volume	0.46x
Share Based Comp	180,604,000
Tr6m	132.44%
Us State	California
Volume	2,124,997

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does RVMD pay a dividend?

Capital-return profile for this ticker.

Performance

RVMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RVMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.1%

Float: +90.9% of shares outstanding

Insider ownership

+2.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RVMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.4

Neutral momentum band

Price vs 200-day MA

+79.4%

50/200-day relationship not available

Beta (5Y)

1.41

More volatile than the market

Sharpe ratio

2.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RVMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RVMD stock rating?

Revolution Medicines, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RVMD analysis?

The full report lives at /stocks/RVMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RVMD?

The latest report frames RVMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RVMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.